GSK, Human Genome in co-development project

07/8/2005 | American City Business Journals

GlaxoSmithKline plans to co-develop a rheumatoid arthritis drug being tested by Human Genome Sciences. GSK said it would exercise its co-development option under a 1996 agreement between the two firms, with both companies sharing the costs of late-stage clinical trials and marketing costs if the drug is commercialized.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR